Bioinformatic analysis reveals the key pathways and genes in early-onset breast cancer
- PMID: 29644522
- DOI: 10.1007/s12032-018-1130-7
Bioinformatic analysis reveals the key pathways and genes in early-onset breast cancer
Abstract
Early-onset breast cancer is the most prevalent cancer in the female. To identify the differentially expressed genes and the key signaling pathways in early-onset breast cancer, we have carried out the bioinformatic analysis of an RNA array dataset in the GEO database, GSE109169, which was acquired from early-onset breast cancer patient. A total of 118 differentially expressed genes in early-onset breast cancer were significantly changed compared with that in adjacent normal tissues. Most of these genes are classified into three categories: signaling molecule, enzyme modulator, and hydrolase. Gene ontology terms reveal that most of these genes are involved in cellular and metabolic processes, biological regulation, binding and catalytic activities, and receptor regulation. Protein-protein interaction network was constructed and has two highly enriched modules: one with up-regulated genes and the other with down-regulated genes. The singling pathways are mainly enriched in the cellular immune system, lipid metabolism and other types of metabolic pathways. Finally, we have plotted the Kaplan-Meier curves of two up-regulated and two down-regulated genes for the overall survival prediction in breast cancer. These results greatly expand the current view of early-onset breast cancer and shed light on the discovery of drug candidates and the improvement for the prognosis.
Keywords: Bioinformatic analysis; Early-onset breast cancer; Gene ontology and pathway analysis; Protein–protein interactions.
Similar articles
-
High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.Anticancer Res. 2017 Aug;37(8):4329-4335. doi: 10.21873/anticanres.11826. Anticancer Res. 2017. PMID: 28739725
-
Screening of Prognostic Factors in Early-Onset Breast Cancer.Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033819893670. doi: 10.1177/1533033819893670. Technol Cancer Res Treat. 2020. PMID: 32028860 Free PMC article.
-
Screening of the prognostic targets for breast cancer based co-expression modules analysis.Mol Med Rep. 2017 Oct;16(4):4038-4044. doi: 10.3892/mmr.2017.7063. Epub 2017 Jul 21. Mol Med Rep. 2017. PMID: 28731166 Free PMC article.
-
Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system.Mol Biol Rep. 2019 Apr;46(2):2111-2119. doi: 10.1007/s11033-019-04663-4. Epub 2019 Mar 19. Mol Biol Rep. 2019. PMID: 30888555
-
Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.Cancer Biomark. 2017 Dec 12;21(1):373-381. doi: 10.3233/CBM-170550. Cancer Biomark. 2017. PMID: 29081411
Cited by
-
Identification of osteoporosis markers through bioinformatic functional analysis of serum proteome.Medicine (Baltimore). 2020 Sep 25;99(39):e22172. doi: 10.1097/MD.0000000000022172. Medicine (Baltimore). 2020. PMID: 32991410 Free PMC article.
-
CCNB1 is a novel prognostic biomarker and promotes proliferation, migration and invasion in Wilms tumor.BMC Med Genomics. 2023 Aug 17;16(1):189. doi: 10.1186/s12920-023-01627-3. BMC Med Genomics. 2023. PMID: 37592341 Free PMC article.
-
Key Genes and Prognostic Analysis in HER2+ Breast Cancer.Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033820983298. doi: 10.1177/1533033820983298. Technol Cancer Res Treat. 2021. PMID: 33499770 Free PMC article.
-
Transcriptome Analysis of Bovine Rumen Tissue in Three Developmental Stages.Front Genet. 2022 Mar 3;13:821406. doi: 10.3389/fgene.2022.821406. eCollection 2022. Front Genet. 2022. PMID: 35309117 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical